FGF19 FGF15 enterokine
Selected indexed studies
- Metabolic Messengers: fibroblast growth factor 15/19. (Nat Metab, 2019) [PMID:32694803]
- FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations. (Mol Metab, 2021) [PMID:33171307]
- A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophy. (J Pathol, 2023) [PMID:37650293]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Metabolic Messengers: fibroblast growth factor 15/19. (2019) pubmed
- FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations. (2021) pubmed
- A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophy. (2023) pubmed
- Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice. (2017) pubmed
- Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice. (2017) pubmed
- Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling. (2022) pubmed
- FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. (2011) pubmed
- Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. (2017) pubmed
- Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. (2013) pubmed